### **MEMORY: (End of Iteration 3)**

*   **State:** Numeric Validation protocol NV-03 is complete. This iteration successfully confronted the two primary deficiencies identified in the prior loop: the static world assumption and the manual creation of the safety model. The prototype now incorporates a predictive physics model and a specification for a trusted data ingestion pipeline.

*   **Architecture:**
    1.  **Dynamic Tissue Model (DTM):** The `AnatomicalSafetyModel` architecture has been fundamentally extended. The static Octree is now augmented by a `DynamicTissueModel`, which uses a linear elastic (mass-spring) lattice to predict tissue deformation in response to applied force from the surgical manipulator. This DTM replaces the static `safety_margin_mm`, allowing the system to operate in tighter spaces by calculating necessary clearance dynamically.
    2.  **Verification Kernel Enhancement:** The kernel's function `is_path_safe` has been superseded by `is_trajectory_safe(path, force_profile)`. The check is now a two-stage process:
        *   **Stage 1 (Coarse Check):** The planned tool path is checked against the static Octree for gross collisions.
        *   **Stage 2 (Predictive Check):** For path segments proximate to tissue boundaries, the kernel queries the DTM to predict the volumetric displacement of tissue. It then re-checks for collision against this *predicted future state*. The trajectory is rejected if the deformed tissue volume would intersect a no-go zone.
    3.  **Scan-to-Model Specification:** A formal specification for a trusted toolchain has been designed to automate the conversion of medical DICOM scans into a verified Octree ASM.

*   **Validation NV-03 Summary:**
    *   **Pipeline Fidelity Test:** A synthetic 3D phantom with known geometric properties was algorithmically converted into an Octree ASM. The volumetric error between the resulting model and the ground-truth phantom was below the 0.5% tolerance threshold, validating the geometric integrity of the proposed scan-to-model process.
    *   **Predictive Safety Test:** In a simulation, a robotic tool was advanced towards a deformable tissue model represented by the DTM. The DTM correctly predicted that the applied force would deform the tissue into a deeper, critical region. The Verification Kernel, using this prediction, arrested the tool's motion *before* any physical contact with the critical boundary occurred, validating the core principle of predictive safety.

---

### **LESSONS_LEARNT: (Iteration 3)**

1.  **Computation is the New Bottleneck.** While the DTM provides a far more elegant solution to the safety margin problem, it comes at a steep computational price. The deformation prediction requires solving a system of equations that, even for our simplified linear model, introduces latency. During NV-03, the verification loop's cycle time was an order of magnitude slower than the required rate for a seamless haptic feedback link (~1 KHz). The critical path is no longer algorithmic correctness, but **time-bounded, provably-correct computation**. The architecture must now evolve to consider model order reduction techniques and potentially offloading the DTM calculations to specialized hardware like FPGAs or dedicated physics processors.

2.  **The Model is Only as Good as its Parameters.** The accuracy of the DTM is wholly dependent on the material properties (i.e., Young's Modulus, Poisson's ratio) assigned to the tissue model. We used a single, uniform value for the simulation. This is a gross simplification. In reality, these properties are patient-specific, non-uniform, and anisotropic. The system requires a mechanism for **in-situ mechanical characterization**—a protocol for the surgical tool itself to perform micro-indentations, measure the force-displacement response, and update the DTM's parameters in real-time. The safety model cannot be static; it must be adaptive.

3.  **The Simulation-Reality Gap.** We have verified that the kernel correctly implements the physics of our DTM. We have not, however, validated that the DTM's physics accurately represent *real tissue*. We are approaching the limits of what can be proven in a purely digital environment. The largest unquantified risk is now the fidelity of our simulation to physical law. The next iteration must move beyond simulation and into the domain of physical validation. A hardware-in-the-loop testbed using calibrated tissue phantoms is no longer optional; it is the next logical and necessary step to prove the system's viability.